A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

Sponsor: Jon Husted (Republican-OH)July 30, 2025

AI-generated ?

Report an error

Introduced

In Committee

Passed One Chamber

Passed Both Chambers

Signed into Law

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

AI summary is being generated. Check back soon!

View on Congress.gov

S 2529 · 119th Congress · July 30, 2025

Lobbying Activity

5 filings mentioned this bill

Top Lobbying Clients

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

$359.2K

2 filings

CHATTEM, INC. DBA OPELLA

$70K

1 filing

HALEON US HOLDINGS LLC

2 filings

Top Lobbying Firms

1.CONSUMER HEALTHCARE PRODUCTS ASSOCIATION2 filings

2.HALEON US HOLDINGS LLC2 filings

3.AKIN GUMP STRAUSS HAUER & FELD1 filing

Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.

Take Action on This Bill

Write a Letter

Send a letter to your representatives via ResistBot

Text 50409 Open ResistBot

Take Action on This Bill

Write a Letter

Send a letter to your representatives via ResistBot

Text 50409 Open ResistBot

5 filings mentioned this bill

Top Lobbying Clients

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

$359.2K

2 filings

CHATTEM, INC. DBA OPELLA

$70K

1 filing

HALEON US HOLDINGS LLC

2 filings

Top Lobbying Firms

1.CONSUMER HEALTHCARE PRODUCTS ASSOCIATION2 filings

2.HALEON US HOLDINGS LLC2 filings

3.AKIN GUMP STRAUSS HAUER & FELD1 filing

Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.